The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

One popular option, Weight Loss by Hers, is a holistic program personalized for you. The program features four pillars of ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Zepbound is approved to treat obesity, and Mounjaro is approved for diabetes. They use the same active ingredient: tirzepatide.Ozempic, for diabetes, and Wegovy, for weight loss, use the active ...